Sponsors

Each year the Bacteraemia and Respiratory programmes are sponsored by a group of pharmaceutical companies. There are several major advantages for sponsors associated with the programmes. Firstly, it is an extremely economical way to obtain information about their molecule’s performance against recent relevant isolates because the costs of collecting the isolates and testing the panel of comparator agents are shared. Secondly, when results are published, they have the added credibility of having been obtained in a study run by an independent scientific society rather than by an individual company. Thirdly, several hundred microbiologists and clinicians have registered to use our website because they value the programmes and make use of the information they produce.

If you are interested in finding out more about the benefits of becoming a sponsor please contact us and we will be delighted to discuss the options available in more detail.

Below is a list of companies that have sponsored the programmes:

Company *Season
Abbot Laboratories
abbott
2000
2001
2002
2003
Astellas
2007
2008
2009
2010
2011
AstraZeneca
2006 2013
2007 2014
2008
Aventis Pharma
2000
2001
Basilea
2011
2012
2013
2014
Bayer Pharmaceuticals
2000 2014
2001
2002
2003
2004
Cempra
2012
Cerexa
2008
2009
Cubist Pharmaceuticals
cubist
2003 2013
2011 2014
2012
GeneSoft Pharmaceuticals
2003
GlaxoSmithKline
2000
2001
2002
Johnson & Johnson Pharmaceutical Research & Development
2005 2010
2006 2011
2007
2008
2009
Merck Sharp & Dohme
2001 2006
2002 2007
2003
2004
2005
Novartis
2005 2010
2006
2007
2009
Pfizer
2001 2006 2011
2002 2007 2012
2003 2008 2013
2004 2009
2005 2010
Theravance
2005
2006
Wyeth
2001 2006
2002 2007
2003 2008
2004 2009
2005

Associate Sponsors

Company *Season
Basilea 2003
2004
2011
Cerexa 2009
Melinta 2013
Theravance 2007

* A surveillance ‘season’ (e.g. 2001) applies to sponsorship of the bacteraemia study of that year (e.g. 2001) and/or the respiratory study starting the autumn before (e.g. 2000/2001).